APA (7th ed.) Citation

Willmann, S., Lloyd, A., Austin, R., Joseph, S., Solms, A., Zhang, Y., . . . Schultze‐Mosgau, M. (2024). Population pharmacokinetic–pharmacodynamic model of elinzanetant based on integrated clinical phase I and II data. CPT: pharmacometrics and systems pharmacology, 13(12), 2137-2149. https://doi.org/10.1002/psp4.13226

Chicago Style (17th ed.) Citation

Willmann, Stefan, Adam Lloyd, Rupert Austin, Shiju Joseph, Alexander Solms, Yang Zhang, Annika R. P. Schneider, Sebastian Frechen, and Marcus‐Hillert Schultze‐Mosgau. "Population Pharmacokinetic–pharmacodynamic Model of Elinzanetant Based on Integrated Clinical Phase I and II Data." CPT: Pharmacometrics and Systems Pharmacology 13, no. 12 (2024): 2137-2149. https://doi.org/10.1002/psp4.13226.

MLA (9th ed.) Citation

Willmann, Stefan, et al. "Population Pharmacokinetic–pharmacodynamic Model of Elinzanetant Based on Integrated Clinical Phase I and II Data." CPT: Pharmacometrics and Systems Pharmacology, vol. 13, no. 12, 2024, pp. 2137-2149, https://doi.org/10.1002/psp4.13226.